The Regulatory Review

Lights, Camera, Deception | The Regulatory Review

Scholars argue that regulators and celebrities must work to halt ads for miracle weight loss products. Celebrity endorsements draw heightened public attention. U.S. Senator Maggie Hassan (D-N.H.) questioned Mehmet Oz, a former television host and the administrator of the Centers for Medicare & Medicaid Services, about his advertisement of miracle weight loss products (MWLPs)—over-the-counter supplements…

Read More
Trump, Tylenol and the Plaintiffs Bar

Trump, Tylenol and the Plaintiffs Bar

We’ll admit we didn’t see this coming: President Trump advising pregnant women against using one of the most ubiquitous over-the-counter medicines in America. That’s what happened Monday when Mr. Trump joined his health advisers in linking acetaminophen, the main ingredient in Tylenol, to autism. What’s going on here has less to do with healthcare than…

Read More
China achieves invisibility tech breakthrough for early warning aircraft

China achieves invisibility tech breakthrough for early warning aircraft

Airborne early warning and control (AEW&C) aircraft – long considered indispensable yet vulnerable command nodes – have historically been high-value targets. Their powerful radar emissions, while essential for managing the battlespace, make them visible from hundreds of kilometres away. But the Chinese scientists said they found a way to make AEW&C signals exceptionally resistant to…

Read More
Innovent, BeOne are poised for profits in 2025, in milestone for Chinese biotech start-ups

Innovent, BeOne are poised for profits in 2025, in milestone for Chinese biotech start-ups

A pair of Hong Kong-listed mainland Chinese biotechnology firms are poised to turn a profit this year as their revenue from novel drugs finally outstrips costs related to research and development and marketing, according to analysts. “Chinese biotechs have matured significantly and are creating value for Chinese patients and government payers,” said Tony Ren, head…

Read More